FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: procter & gamble

Sort
E.g., 2013-05-24
E.g., 2013-05-24
Enter a comma separated list of user names.

The Procter & Gamble Company (NYSE:PG) is focused on providing consumer packaged goods. The Procter & Gamble Company achieved its new 52 week high price of $67.77 where it was opened at $67.41 up 0.23 points or +0.34% by closing at $67.62. PG transacted shares during the day were over 14.74 million shares however it has an average volume of 12.34 million shares.

The Procter & Gamble Company (NYSE:PG) is focused on providing consumer packaged goods. The Procter & Gamble Company achieved its new 52 week high price of $67.04 where it was opened at $66.57 down -0.01 points or -0.01% by closing at $66.70. PG transacted shares during the day were over 17.91 million shares however it has an average volume of 13.41 million shares.

Uptrend of The Procter & Gamble Company - NYSE:PG

Posted by david on February 27th, 2012

The Procter & Gamble Company (NYSE:PG) is focused on providing consumer packaged goods. The Procter & Gamble Company achieved its new 52 week high price of $66.95 where it was opened at $66.74 UP 0.29 points or +0.44% by closing at $66.71. PG transacted shares during the day were over 17.78 million shares however it has an average volume of 13.41 million shares.

Thor Industries, Inc. (NYSE:THO) announced preliminary sales, backlog, and cash & investments for the quarter and six months ended January 31, 2011. Preliminary consolidated sales in the quarter were $524,662,000, up 22% from $430,025,000 last year. RV sales were $436,113,000, up 30% from $335,796,000 last year.

Power3 Medical Products, Inc. (PWRM.OB) previously reported that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

Pages

ADVERTISE WITH US